Aegle Therapeutics Corp

Biotechnology company · Woburn, Massachusetts, United States

Aegle Therapeutics Corp is a biotechnology company headquartered in Woburn, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $455,695 sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Aegle Therapeutics at a glance

Typebiotechnology company

HeadquartersWoburn, Massachusetts, United States

Earliest incorporation on record2019

SEC CIK1797825

What does Aegle Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $455,695 sold (2026).

Frequently asked questions about Aegle Therapeutics

Where is Aegle Therapeutics headquartered?

Aegle Therapeutics Corp is headquartered in Woburn, Massachusetts, United States.

What does Aegle Therapeutics do?

Aegle Therapeutics Corp is a biotechnology company.

When was Aegle Therapeutics founded?

The earliest incorporation on record for Aegle Therapeutics Corp is in 2019, according to public company registers.

Similar companies

ImmunoMolecular Therapeutics, Inc.Woburn, Massachusetts, United States
Hearthstone Alzheimer Care Ltd.Woburn, Massachusetts, United States
PNA Innovations, Inc.Woburn, Massachusetts, United States
SeqLL, Inc.Woburn, Massachusetts, United States
Terrestrial Bio, Inc.Woburn, Massachusetts, United States
Alloplex Biotherapeutics, Inc.Woburn, Massachusetts, United States
Replimune Group, Inc.Woburn, Massachusetts, United States
Neurogastrx, Inc.Woburn, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences